United States: CMMI Issues Report On Status Of Pending Drug Models - Manatt, Phelps & Phillips LLP
Friday, 3 November 2023
The Center for Medicare and Medicaid Innovation (CMMI) has provided new updates on CMS' planned initiatives to address prescription drug costs in a blog post from Director Liz Fowler.
|
||||
You Might Like |
||||
